Does Rallies show 13F holders for BOLD?

Yes. Rallies tracks hedge fund and 13F ownership data for BOLD, including fund names, share counts, latest tracked quarter, and position changes when available.

Is BOLD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BOLD. It does not provide personalized investment advice.

BOLD (Boundless Bio, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Boundless Bio, Inc. Common Stock (BOLD) is a publicly traded Healthcare sector company. As of May 21, 2026, BOLD trades at $1.42 with a market cap of $31.90M and a P/E ratio of -0.55. BOLD moved +0.00% today. Year to date, BOLD is +20.34%; over the trailing twelve months it is -14.46%. Its 52-week range spans $0.96 to $3.75. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces BOLD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BOLD stock?

Hedge funds tracked by Rallies that own BOLD include Redmile Group and Soros Fund. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Boundless Bio, Inc. Common Stock.

BOLD Key Metrics

Key financial metrics for BOLD
Metric	Value
Price	$1.42
Market Cap	$31.90M
P/E Ratio	-0.55
EPS	$-2.60
Dividend Yield	0.00%
52-Week High	$3.75
52-Week Low	$0.96
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-58.20M
Gross Margin	0.00%

Top Hedge Funds Holding BOLD

Redmile Group holds 245.46K shares of BOLD, changed -58.33% as of Sep 30, 2025.
Soros Fund holds 20.00K shares of BOLD, changed +0.00% as of Mar 31, 2024.

Latest BOLD News

Boundless Bio Secures FDA IND for BBI-940, Opens KOMODO-1 Trial with $107.6M Runway — Mar 9, 2026
Boundless Bio Upgraded to Zacks Rank #2 After 34.5% EPS Estimate Surge — Feb 13, 2026

Recent BOLD Insider Trades

Burow Kristina bought 66.67K (~$1.07M) on Apr 2, 2024.
Burow Kristina bought 133.33K (~$2.13M) on Apr 2, 2024.
CRANDELL KEITH bought 66.67K (~$1.07M) on Apr 2, 2024.

BOLD Analyst Consensus

1 analysts cover BOLD: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.

Common questions about BOLD

Who owns BOLD stock?: Hedge funds tracked by Rallies that own BOLD include Redmile Group and Soros Fund. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Boundless Bio, Inc. Common Stock.
Does Rallies show 13F holders for BOLD?: Yes. Rallies tracks hedge fund and 13F ownership data for BOLD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BOLD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BOLD. It does not provide personalized investment advice.